DrGeorge Eleje

Dr George Eleje is a senior Lecturer and Consultant in the department of Obstetrics and Gynaecology with special interest in Preterm birth, Evidence based medicine (Cochrane systematic Reviews), Infectious diseases and HIV medicine (particularly Prevention of Mother to Child Transmission of HIV/Hepatitis and adolescent HIV prevention). He has more than 7 years’ experience as a Consultant. He is currently the Research Co-ordinator at the Effective Care Research Unit, Nnamdi Azikiwe University, Nnewi Campus, Nigeria. He previously held the role of Deputy Editor, Afrimedic Journal and currently contributing to capacity building in training of over 400 Medical Students and trainee Resident Doctors in Nigeria. I am a reviewer to ten international Journals including Cochrane Database of Systematic Reviews. He is a Consultant on reproductive health issues for West African Health Organisation (WAHO) on cervical cancer. He is a Fellow of the South African Cochrane Center through a grant received from the Effective Health Care Research Consortium www.evidence4health.org. DR Eleje is a contact person for three of Cochrane Systematic Reviews and co-author on four others in progress. Notable about the Cochrane reviews is our currently registered title, which we are currently developing its protocol titled: “Antivirals for prevention of hepatitis B virus mother-to-child transmission in human immunodeficiency virus positive pregnant women co-infected with hepatitis B virus”. He has published widely in international and notable national journals on HIV, PMTCT, preterm births and related fields. Dr Eleje has also attended 3rd African Cochrane indaba through a grant from tdr global. Presently, He is a mentor to an ongoing HIV-related EDCTP grant titled: “Conditional economic incentives and motivational interviewing to improve adolescents' retention in HIV care and adherence to antiretroviral therapy in Southeast Nigeria: a cluster randomised trial”, with Grant support number:TMA2016CDF-1548/European and Developing Countries Clinical Trials Partnership/